Vincent Leroy - Publications

When Tobacco and Cannabis Use Motives Interact: Implications for Dependence and Quitting.

Journal: Substance use & misuse

Published: September 06, 2026

Hepatic multimodal phenotyping in AL amyloidosis with cardiac involvement: the D-Amy-LIPHE study.

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Published: July 06, 2026

Dried Blood Spot: A Tool to Ensure Broad Access to Hepatitis D Screening, Diagnosis, and Treatment Monitoring.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: February 09, 2026

Clinical impact of extrahepatic metastatic patterns in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 14, 2026

Simultaneous versus Sequential Cessation of Tobacco and Cannabis: Preferences of Young Adults Who Co-Use in France.

Journal: Drug and alcohol review

Published: December 16, 2025

Hepatitis D Virus Seroconversion Rate Among People With Chronic Hepatitis B Virus Infection in France and The Gambia (Inci-D).

Journal: Open forum infectious diseases

Published: December 05, 2025

Hepatitis D Virus Seroconversion Rate Among People With Chronic Hepatitis B Virus Infection in France and The Gambia (Inci-D).

Journal: Open forum infectious diseases

Published: December 05, 2025

Crossed Pathways: Tobacco-Cannabis Co-Use and Motivation to Quit in Young Adults in France.

Journal: Drug and alcohol review

Published: December 03, 2025

Corrigendum to: "Evaluation of a delayed liver transplantation strategy for patients with HCC receiving bridging therapy: the DELTA-HCC study" [J Hepatol (2024) 278-288].

Journal: Journal of hepatology

Published: October 28, 2025

When social inequities dictate outcomes: the multidisciplinary call of cholangiocarcinoma.

Journal: The Lancet regional health. Europe

Published: September 17, 2025

Pembrolizumab versus pembrolizumab plus chemotherapy in patients with PDL1 ⩾50% advanced non-small-cell lung cancer, depending on tumor aggressiveness and clinical impact.

Journal: Therapeutic advances in medical oncology

Published: August 13, 2025

On the validity of Wood's law: From bubbly media to liquid foams.

Journal: Ultrasonics

Published: June 23, 2025